Weekend strokes more deadly – but why?
November 1, 2010 — NEW YORK (Reuters Health) – Yet another study has shown that people who are treated for stroke over a weekend tend to fare worse than those who are treated during the week, but the reasons remain unclear. Black patients fare well on new hepatitis C drug November 1, 2010 — NEW YORK (Reuters) – A closer look at data from a late stage trial of Vertex Pharmaceuticals Inc’s eagerly anticipated hepatitis C drug called telaprevir showed impressive cure rates for black patients and for patients with advanced liver disease.
